Company profile for RS BioTherapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

RS BioTherapeutic’s first investigational compound (RSBT-001) is a semi-synthetic, nebulized, cannabidiolic acid complex in development to address exacerbation and prevent progression of both acute and chronic pulmonary inflammation related to respiratory diseases including COPD, SARS-COV-2, Cystic Fibrosis, Asthma, Bronchitis, and Acute Respiratory Distress Syndrome. Our premise is that RSBT1 provides therapeutic benefit th...
RS BioTherapeutic’s first investigational compound (RSBT-001) is a semi-synthetic, nebulized, cannabidiolic acid complex in development to address exacerbation and prevent progression of both acute and chronic pulmonary inflammation related to respiratory diseases including COPD, SARS-COV-2, Cystic Fibrosis, Asthma, Bronchitis, and Acute Respiratory Distress Syndrome. Our premise is that RSBT1 provides therapeutic benefit through modulation of the Interleukin response to inflammation and modulation of alveolar macrophages responsible for fibrotic changes within the lungs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Cumberland, MD 21502
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/01/21/3012830/0/en/RS-BioTherapeutics-Announces-Positive-Anti-Inflammatory-and-Anti-Fibrotic-Effects-of-Lead-Compound-in-Human-Lung-Tissue.html

GLOBENEWSWIRE
21 Jan 2025

https://www.globenewswire.com/news-release/2024/07/08/2909738/0/en/RS-BioTherapeutics-Announces-Research-Collaboration-with-University-of-Colorado-School-of-Medicine.html

GLOBENEWSWIRE
08 Jul 2024

https://www.globenewswire.com/news-release/2024/04/30/2872441/0/en/RS-BioTherapeutics-Launches-Crowdfunding-Campaign-Through-StartEngine.html

GLOBENEWSWIRE
30 Apr 2024

https://www.globenewswire.com/news-release/2024/04/25/2869782/0/en/RS-BioTherapeutics-Adds-Jane-Wright-Mitchell-Pharm-D-J-D-to-Business-Advisory-Board.html

GLOBENEWSWIRE
25 Apr 2024

https://www.globenewswire.com/news-release/2024/03/18/2847984/0/en/RS-BioTherapeutics-Selected-for-Presentation-at-American-Thoracic-Society-s-2024-Respiratory-Innovation-Summit.html

GLOBENEWSWIRE
18 Mar 2024

https://www.globenewswire.com/news-release/2024/03/18/2847984/0/en/RS-BioTherapeutics-Selected-for-Presentation-at-American-Thoracic-Society-s-2024-Respiratory-Innovation-Summit.html

GLOBENEWSWIRE
18 Mar 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty